$FOLD Headlines Apple

New Post Public Reply Private Reply Replies (0) Message Board

Sep 24, 2014 at 12:32 PM

$FOLD Headlines

Apple sets intraday record; PetSmart considers sale
1:56 p.m. Aug. 20, 2014
- Ben Eisen

Amicus Therapeutics shares up 25.6% in premarket trade
8:05 a.m. Aug. 20, 2014
- Ciara Linnane

Amicus Therapeutic’s Fabry treatment meets goals in late-stage trial
8:04 a.m. Aug. 20, 2014
- Michael Calia

U.S. stocks rise as risk appetite returns
5:19 p.m. April 29, 2014
- Anora Mahmudova

Twitter rallies ahead of earnings; 3D Systems retreats
3:49 p.m. April 29, 2014
- Sue Chang

U.S. stock futures climb; House prices flat in February
9:19 a.m. April 29, 2014
- Barbara Kollmeyer

Amicus rallies 52% premarket after positive trial results
7:25 a.m. April 29, 2014
- Sara Sjolin

Amicus rallies 52% premarket after positive trial results
7:08 a.m. April 29, 2014
- Sara Sjolin

Amicus stock down after it delays seeking Fabry OK
10:44 a.m. June 17, 2013
- MarketWatch.com

Friday’s biggest gaining and declining stocks
10:45 a.m. Jan. 4, 2013
- Greg Morcroft

Amicus Therapeutics up 11% in premarket
8:52 a.m. Jan. 4, 2013
- Steve Gelsi

Thursday’s movers: Apple ends in red on price cut
6:03 p.m. Dec. 20, 2012
- Sue Chang

Amicus down 45% in premarket
9:44 a.m. Dec. 20, 2012
- Steve Gelsi

Amicus falls 47% in premarket trades
8:52 a.m. Dec. 20, 2012
- Steve Gelsi

Bed Bath shares hurt, Jabil climbs after hours
7:31 p.m. Dec. 19, 2012
- Carla Mozee

Amicus, GlaxoSmithKline say treatment misses goal
6:22 p.m. Dec. 19, 2012
- MarketWatch.com

Amicus Therapeutics shares tumble 49% after hours
5:45 p.m. Dec. 19, 2012
- Carla Mozee

U.S. Hot stocks to watch
7:28 a.m. July 18, 2012
- MarketWatch.com

U.S. may end patents on DNA: report
1:13 p.m. Oct. 30, 2010
- Christopher Hinton

Monday's biggest gaining and declining stocks
4:51 p.m. Oct. 5, 2009
- MarketWatch

3 Cheap Biotech Stocks Analysts Love: Ohr Pharmaceutical Inc, Merrimack & Amicus

1:25 p.m. Sept. 8, 2014
- benzinga.com

Why Amicus Therapeutics (FOLD) Stock Might be a Great Pick - Tale of the Tape

8:36 a.m. Sept. 3, 2014
- Zacks.com

InsiderInsights.com Daily Round Up 8/29/14: Prospect Capital, THL Credit, Kindred Biosciences, Select Medical

10:13 a.m. Aug. 30, 2014
- Seeking Alpha

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog

10:32 a.m. Aug. 27, 2014
- Zacks.com

Amicus Therapeutics Hits 52-Week High on Migalastat Data - Analyst Blog

9:49 a.m. Aug. 27, 2014
- Zacks.com

The Biotech Stock With The Best One-Week Performance

2:46 p.m. Aug. 25, 2014
- benzinga.com

Amicus Therapeutics (FOLD) Soars on Fabry Drug Trial Results - Analyst Blog

4:55 p.m. Aug. 21, 2014
- Zacks.com

Perilous Reversal Stock: Amicus Therapeutics (FOLD)

9:45 a.m. Aug. 21, 2014
- TheStreet.com

Amicus Therapeutics (FOLD) Worth Watching: Stock Rises 20.4% - Tale of the Tape

9:39 a.m. Aug. 21, 2014
- Zacks.com

Can the Rally in Amicus Therapeutics (FOLD) Shares Continue? - Tale of the Tape

9:03 a.m. Aug. 21, 2014
- Zacks.com

Amicus Therapeutics' (FOLD) CEO John Crowley on Phase III Fabry Monotherapy Study Results (Transcript)

3:43 p.m. Aug. 20, 2014
- Seeking Alpha

Why Amicus Therapeutics (FOLD) Stock Hit a One-Year High Today

10:29 a.m. Aug. 20, 2014
- TheStreet.com

Stocks Hitting 52-Week Highs

9:15 a.m. Aug. 20, 2014
- benzinga.com

Amicus Fabry disease drug candidate successful in Phase 3 trial

7:27 a.m. Aug. 20, 2014
- Seeking Alpha

Benzinga's Top #PreMarket Gainers

7:10 a.m. Aug. 20, 2014
- benzinga.com

Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win

6:01 a.m. Aug. 20, 2014
- TheStreet.com

Amicus' (FOLD) CEO John Crowley on Q2 2014 Results - Earnings Call Transcript

9:37 p.m. Aug. 7, 2014
- Seeking Alpha

10-Q: AMICUS THERAPEUTICS INC
5:07 p.m. Aug. 7, 2014
- Edgar Online - (EDG = 10Q, 10K)

Why Amicus Therapeutics (FOLD) Might Surprise This Earnings Season - Tale of the Tape

8:44 a.m. Aug. 6, 2014
- Zacks.com

Amicus (FOLD) Shares March Higher, Can It Continue? - Tale of the Tape

11:11 a.m. July 29, 2014
- Zacks.com

Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics
8:40 a.m. Sept. 12, 2014
- PR Newswire - PRF

Clinical Trial Results, Change of Corporate Name, New Products, and Completion of Acquisition - Research Reports on GSK, Amicus, WellPoint, IDEXX and Endo
8:40 a.m. Aug. 25, 2014
- PR Newswire - PRF

Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012
6:00 a.m. Aug. 20, 2014
- GlobeNewswire

Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics
8:50 a.m. Aug. 13, 2014
- PR Newswire - PRF

Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates
4:01 p.m. Aug. 7, 2014
- GlobeNewswire

Amicus Therapeutics to Announce Second Quarter 2014 Financial Results on August 7, 2014
4:01 p.m. July 31, 2014
- GlobeNewswire

Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis
8:50 a.m. July 30, 2014
- PR Newswire - PRF

Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma
7:20 a.m. July 10, 2014
- PR Newswire - PRF

Amicus Therapeutics Analyst Report; Solid Pipeline and Near-term Catalysts by BrokerBank Securities, Inc.
2:55 p.m. July 7, 2014
- PR Newswire - PRF

Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array
6:30 a.m. July 3, 2014
- PR Newswire - PRF

Amicus Therapeutics Provides Updates and Final Analysis Plan for Phase 3 Fabry Monotherapy Study 012
7:00 a.m. June 30, 2014
- GlobeNewswire

Technical Coverage on Top Gainers -- Research on Fresh Market, First Bancorp, Amicus Therapeutics, and Magellan Petroleum
8:20 a.m. June 4, 2014
- PR Newswire - PRF

Amicus Therapeutics to Present at UBS Global Healthcare Conference
4:10 p.m. May 14, 2014
- GlobeNewswire

Amicus Therapeutics Announces First Quarter 2014 Financial Results and Corporate Updates
4:01 p.m. May 5, 2014
- GlobeNewswire

Dr. Farzad Mostashari to keynote SAS Health Analytics Executive
Conference
10:30 a.m. May 5, 2014
- BusinessWire - BZX

Positive Data, Financial Results, and Drug Development Programs - Analyst Notes on Novavax, Ironwood, XOMA, Luminex and Amicus
8:00 a.m. May 2, 2014
- PR Newswire - PRF

Amicus Therapeutics to Announce First Quarter 2014
10:01 a.m. May 1, 2014
- GlobeNewswire

Morning Review on Top Gainers -- Research on Banco Santander Brasil, Novavax, Cadence Design Systems, and Amicus Therapeutics
8:00 a.m. April 30, 2014
- PR Newswire - PRF

Amicus Therapeutics Announces Positive 12- and 24-Month Data From Phase 3 Fabry Monotherapy Study 011
6:01 a.m. April 29, 2014
- GlobeNewswire

Amicus Therapeutics to Present at 13th Annual Needham Healthcare Conference
4:39 p.m. March 27, 2014
- GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Smart Salary Moves for S Corp Owners: Riggs Unpacks Insights

Decoding the S Corp Salary Dance How much salary should the savvy owners of S corporations draw? It ain't a simple task or one-size-fits-all deal, folks. David Riggs spills the beans on HelloNation, sharing insights on this complex tango between drawing wages and raking in shareholder distributions. In the end, it’s about playing by the IRS rules—or risking a penalty...

Decoding LRV: Smart Paint Choices for Your Home

Unraveling the Secrets of LRV Nobody thought analyzing paint meant diving into light reflectance values (LRV), but that's precisely where we're headed today. Painting a room seems simple until you realize your color choice might turn your bright haven into a cave or vice versa. Thanks to some insights from Wendy Anguiano in HelloNation, let's dig into this technical...

ModelBest & OpenBMB Unveil Open-Source OCR Models

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

XPeng Hits New Monthly Delivery Record in October

XPeng Smashes Delivery Records Yet Again Ah, the green light’s on for XPeng, and it's a bright one! This October, we learned that XPeng hit the throttle hard with a new record of 50,237 vehicles delivered. Now, that's a sizable rally—a 22% climb month-over-month and shooting 20% higher than last October. For a company like XPeng, which resembles a bulldog with its...

NIDS Aims Global with CES 2027, Boosts Sensor Supply

Pushing Boundaries at CES 2027 Kicking into high gear, NIDS Co., Ltd. is eyeing the CES 2027 stage like it's their personal gold rush. Already a heavyweight in environmental sensors, the company is all set to seize fresh international opportunities and expand their B2B supply footprint worldwide. Already Turning Heads Founded back in 2000, NIDS ain't new to the sensor...

Can AI Help Climate? Tech Investments Seek Balance

Is AI a Climate Savior or a Power-Hungry Beast? AI might feel like that unpredictable family member you hope shows up to the party with something useful, but they’ve always got high energy bills. As the tech world touts artificial intelligence as the next big hope for addressing climate woes, folks like Peter Gilmer—who's been around a few boardrooms—are taking a...

Roof Flashing Insights with Expert Jeremiah Lightsey

Why Flashing Is the Backbone of a Leak-Free Roof Ever wonder why some roofs just seem to withstand the wrath of Mother Nature better? The answer, my friends, often boils down to a little unsung hero: roof flashing. Our roof parts aren't exactly playing an even game; you've got chimneys, walls, skylights, just asking for trouble. That's where flashing steps in like an...

SAMILBIO Gambles on 'Chaeyun' Launch With November Events

Can SAMILBIO's New Products Make a Splash? In a world where skincare is more competitive than a hot dog stand outside a vegan festival, here comes SAMILBIO with their latest offerings. Launching a whitening cream and an acne-fighting gel under the 'Chaeyun' brand, this company isn't just sticking to digital—it's diving into face-to-face consumer interaction. I mean,...

DKS Lawsuit Deadline: Investors Must Act by Nov 3, 2026

Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...

Why Accurate HVAC Load Calculations Matter

Beyond Square Footage: Critical HVAC Considerations When it comes to heating and cooling your home, simply considering its square footage is like trying to predict the weather with nothing but a coin flip. Bob Schmid, an HVAC guru from Ocean View, NJ, pulls back the curtain on why the details really matter in determining the most efficient and effective HVAC setup for any...